COVID-19

Top news of the week from Pharmacy Times®.

Student pharmacists across the country have had to adjust their expectations of what P4 year will look like.

An interview with Yashar Rafi, PharmD, 2019-2020 Institute for Safe Medication Practices (ISMP) Medication Safety Management Fellow.

Antibodies isolatied from plasma donated from recovered COVID-19 patients fights the virus that causes COVID-19.

Giant Food has announced that all vaccinations recommended by the ACIP are once again available at its 153 in-store pharmacies across Virginia, Maryland, Delaware, and the District of Columbia.

In addition to adhering to the CDC recommendations, pharmacies should consider workflow changes intended to minimize risk to both patients and the pharmacy staff providing immunization services.

No matter how it all shakes out, pharmacists now have a level of responsibility they never had before.

The expanded delivery services aim to allow customers to continue shopping while staying safely at home during the COVID-19 pandemic.

Current treatment guidelines do not recommend the use of either drug in hospitalized patients with COVID-19 outside of clinical trials.

As the overall data on this illness continue to emerge, it will be important for health care providers to watch its impact on different populations and to serve as a source of reliable information for them.

One of the advantages of specialty pharmacy is the ability to work remotely without compromising the care that pharmacists give to their patients.

Top news of the week from Pharmacy Times®.

Researchers funded by the National Institutes of Health (NIH) have launched an effort to evaluate drugs prescribed to treat coronavirus disease 2019 (COVID-19) in infants, children, and adolescents across the United States.

A new study conducted by researchers at Bar-Ilan University and the University of Haifa has linked coronavirus disease 2019 (COVID-19)-based loneliness in older adults with elevated psychiatric symptoms of anxiety, depression, and trauma symptoms that immediately follow exposure to trauma.

Of 400 dialysis patients with the Vall d’Hebron University Hospital as reference in Barcelona, Spain, 21 contracted the coronavirus disease 2019 (COVID-19) and the mortality rate in this center was 24%, according to the opening presentation at the ERA-EDTA Congress conference.

Concerningly, a majority of respondents also reported disruptions in their regular and preventative health care services.

The COVID-19 pandemic rapidly pushed traditional face-to-face instruction within schools of pharmacy into a fully remote learning environment.

The EUAs are in place for the duration of the coronavirus disease 2019 (COVID-19) pandemic.

There has been more attention been paid to the pulmonary complications of COVID-19, with less attention being paid to the cardiovascular complications that can result in death or impairment.

Critical care drug products are being introduced in the United States to help ease shortages due to the COVID-19 pandemic.

Top news of the week from Pharmacy Times®.

What characteristics of RA treatments possibly connect to COVID-19 treatment?

Pharmacy Times® interviewed Benjamin McNabb, PharmD, the owner of Love Oak Pharmacy, about how pharmacies can protect the communities they serve during the COVID-19 pandemic when reopening or staying open across the country.

Allison Hanson, PharmD, BCPS, the 2019-2020 Institute for Safe Medication Practices (ISMP) International Medication Safety Management Fellow, discusses medication safety during the COVID-19 pandemic.

According to a new survey released by the NCPA, COVID-19 is changing how local pharmacies do business across the country, and these changes may be for the long term.